CN Stock MarketDetailed Quotes
002589 Realcan Pharmaceutical Group
- 3.41
- +0.04+1.19%
Market Closed Nov 8 15:00 CST
5.13BMarket Cap126.30P/E (TTM)
3.55High3.33Low1.53MlotVolume3.46Open3.37Pre Close524.45MTurnover11.23%Turnover Ratio243.57P/E (Static)1.50BShares3.7552wk High0.93P/B4.66BFloat Cap2.0452wk Low3.71Limit Up1.37BShs Float23.92Historical High3.03Limit Down6.53%Amplitude1.90Historical Low0.01Dividend TTM3.42Avg Price752.70KlotAsk0.38%Div YieldTTM100Lot Size738.06KlotBid
Realcan Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.62%6.53B | -8.96%4.04B | -6.54%2.1B | -40.79%8.66B | -47.19%6.77B | -53.21%4.44B | -51.65%2.24B | -38.26%14.63B | -34.75%12.82B | -25.15%9.49B |
| Refunds of taxes and levies | -99.90%20.78K | -99.81%20.78K | ---- | -74.79%22.51M | -75.34%21.82M | -86.95%10.93M | --2.5M | 196.65%89.29M | 579.04%88.51M | 546.55%83.75M |
| Cash received relating to other operating activities | -74.24%124.3M | -61.04%106.5M | -55.70%81.09M | 1.21%568.78M | -36.60%482.46M | -56.73%273.38M | -42.14%183.05M | -72.52%562M | -56.00%761.02M | -43.63%631.82M |
| Cash inflows from operating activities | -8.59%6.65B | -12.18%4.15B | -10.34%2.18B | -39.44%9.25B | -46.78%7.28B | -53.71%4.73B | -50.99%2.43B | -40.71%15.28B | -36.09%13.67B | -26.11%10.21B |
| Goods services cash paid | -4.22%5.99B | -8.40%3.73B | -4.22%2.03B | -35.89%7.66B | -41.58%6.26B | -49.08%4.07B | -42.26%2.12B | -39.90%11.95B | -34.33%10.71B | -21.68%8B |
| Staff behalf paid | 0.07%215.03M | -0.01%143.96M | -5.19%72.38M | -42.54%306.28M | -52.65%214.87M | -55.06%143.97M | -57.17%76.34M | -28.97%533M | -20.91%453.81M | -17.24%320.33M |
| All taxes paid | -0.85%116.28M | -21.18%69.91M | -19.43%31.1M | -67.66%157.81M | -70.68%117.27M | -70.23%88.7M | -78.53%38.59M | -49.09%487.97M | -48.63%399.96M | -46.72%297.96M |
| Cash paid relating to other operating activities | -10.91%316.28M | -18.60%198.81M | -17.23%99.97M | -41.52%1.04B | -80.09%355.02M | -81.49%244.25M | -84.89%120.78M | -52.20%1.78B | -38.31%1.78B | -36.15%1.32B |
| Cash outflows from operating activities | -4.37%6.64B | -8.94%4.14B | -5.17%2.23B | -37.86%9.17B | -47.97%6.95B | -54.21%4.55B | -51.23%2.35B | -41.74%14.75B | -35.06%13.35B | -24.87%9.93B |
| Net cash flows from operating activities | -96.56%11.43M | -94.78%9.33M | -171.55%-54.08M | -84.23%82.47M | 2.13%332.5M | -35.48%178.68M | -42.36%75.59M | 18.09%523.07M | -61.37%325.55M | -53.62%276.93M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --174.38M | --172.05M | --0 | --10.85M | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash received from returns on investments | 974.82%8.63M | 1,064.88%8.62M | 807.80%6.2M | -99.10%295.41K | -81.17%803.08K | 130.52%739.82K | --683K | 60.33%32.77M | 1,751.27%4.26M | 86.47%320.93K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -4.13%35.23M | -30.69%20.11M | -27.73%15.84M | -99.16%708.16K | -65.67%36.75M | -66.16%29.01M | -31.13%21.91M | 528.84%83.97M | 61.60%107.05M | 114.91%85.72M |
| Net cash received from disposal of subsidiaries and other business units | -80.92%151.42M | -81.03%132.96M | -75.67%81.42M | 0.98%1.16B | 13.17%793.54M | 455.59%701M | 353.50%334.58M | 533.79%1.15B | 404.21%701.17M | -0.75%126.17M |
| Cash received relating to other investing activities | -52.86%99M | -37.27%69M | -70.00%3M | -73.85%330M | -81.94%210M | -89.55%110M | -69.37%10M | 1,880.31%1.26B | 4,020.77%1.16B | 4,670.81%1.05B |
| Cash inflows from investing activities | -54.98%468.66M | -52.10%402.74M | -71.01%106.46M | -40.50%1.51B | -47.29%1.04B | -33.53%840.75M | 165.59%367.18M | 803.57%2.53B | 695.01%1.98B | 568.36%1.26B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 18.89%49.37M | -29.93%23.13M | 62.42%12.75M | 74.53%298.38M | -84.33%41.52M | -85.54%33.01M | -89.80%7.85M | -62.92%170.96M | -35.13%264.9M | -12.25%228.29M |
| Cash paid to acquire investments | -80.61%53.95M | --53.95M | --16.42M | 8.59%296.82M | 108.71%278.18M | --0 | --0 | 452.18%273.33M | 370.97%133.29M | 472.04%133.29M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | --0 | ---- | ---- | --0 | -30.99%119.57M | 241.52%234.32M | 241.52%234.32M |
| Cash paid relating to other investing activities | -64.85%99M | -70.21%69M | -97.31%3M | -75.88%331.65M | -76.28%281.61M | -77.29%231.61M | --111.61M | 664.50%1.37B | 969.55%1.19B | 988.72%1.02B |
| Cash outflows from investing activities | -66.35%202.32M | -44.80%146.09M | -73.07%32.17M | -52.19%926.86M | -66.95%601.32M | -83.62%264.63M | -71.12%119.46M | 124.48%1.94B | 195.27%1.82B | 262.50%1.62B |
| Net cash flows from investing activities | -39.44%266.34M | -55.45%256.65M | -70.01%74.29M | -2.26%579.53M | 182.70%439.78M | 264.13%576.13M | 189.96%247.71M | 201.62%592.96M | 142.30%155.57M | -36.84%-351.03M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --0 | --0 | ---- | ---- | --0 | -92.97%207.38K | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --0 | --0 | ---- | ---- | --0 | -92.97%207.38K | ---- | ---- |
| Cash from borrowing | 11.54%4.11B | -9.69%2.53B | -3.71%2.17B | -8.54%5.41B | -24.84%3.68B | -14.36%2.81B | 77.08%2.25B | -9.46%5.91B | -14.42%4.9B | -18.12%3.28B |
| Cash received relating to other financing activities | -8.28%10.86B | -26.98%6.4B | -9.01%3.77B | 79.60%20.81B | -7.05%11.84B | -8.13%8.77B | -21.57%4.15B | -11.02%11.59B | -6.07%12.74B | -6.09%9.54B |
| Cash inflows from financing activities | -3.57%14.97B | -22.79%8.94B | -7.15%5.94B | 49.83%26.22B | -11.99%15.53B | -9.72%11.57B | -2.43%6.4B | -10.51%17.5B | -8.67%17.64B | -9.61%12.82B |
| Borrowing repayment | 5.87%4.44B | -19.04%2.95B | 49.95%2.75B | -8.43%3.97B | -1.71%4.19B | 40.26%3.65B | 61.84%1.83B | -36.31%4.34B | -43.66%4.27B | -47.73%2.6B |
| Dividend interest payment | -42.53%167.14M | -44.78%107.97M | -51.06%67.54M | 21.04%281.84M | -35.03%290.82M | -43.97%195.53M | -3.88%138.01M | -39.25%232.85M | 1.45%447.65M | -12.03%349M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 2.05%80.15M | ---- | ---- | ---- | 17.29%78.54M | 119.57%101.7M | -48.64%15.25M |
| Cash payments relating to other financing activities | -11.53%10.5B | -27.69%5.84B | -30.97%3.02B | 57.31%22.64B | -10.50%11.87B | -15.45%8.08B | -16.76%4.37B | 15.99%14.39B | 9.50%13.27B | 1.83%9.55B |
| Cash outflows from financing activities | -7.62%15.11B | -25.33%8.9B | -8.04%5.83B | 41.82%26.89B | -9.03%16.36B | -4.66%11.92B | -2.85%6.34B | -3.27%18.96B | -10.67%17.98B | -15.26%12.5B |
| Net cash flows from financing activities | 83.47%-136.87M | 110.03%34.78M | 90.76%110.6M | 53.78%-677.2M | -147.00%-827.87M | -209.42%-346.84M | 86.57%57.98M | -2,806.08%-1.47B | 58.51%-335.17M | 155.55%316.97M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | --0 | -123.02%-924.4 | ---- | ---- | --0 | 366.93%4.02K | ---- | ---- |
| Net increase in cash and cash equivalents | 353.44%140.9M | -26.28%300.76M | -65.69%130.81M | 95.65%-15.2M | -138.10%-55.6M | 67.98%407.97M | 437.03%381.29M | -82.79%-349.09M | 143.84%145.94M | 205.57%242.87M |
| Add:Begin period cash and cash equivalents | -3.12%471.94M | -3.12%471.94M | -3.12%471.94M | -41.75%487.14M | -41.75%487.14M | -41.75%487.14M | -41.75%487.14M | -18.59%836.23M | -18.59%836.23M | -18.59%836.23M |
| End period cash equivalent | 42.01%612.85M | -13.68%772.7M | -30.59%602.75M | -3.12%471.94M | -56.06%431.55M | -17.05%895.11M | 20.10%868.43M | -41.75%487.14M | 41.46%982.17M | 35.37%1.08B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Tianyuanquan Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data